The first prospective longitudinal study of outcomes from treatment with direct-acting antivirals (DAAs) suggests the drugs…
Read more
Patients are still at risk of recurrent hepatocellular carcinoma (HCC) after treatment with oral direct-acting antivirals …
Read more
Patients are still at risk of recurrent hepatocellular carcinoma (HCC) after treatment with oral direct-acting antivirals …
Read more
Hepatitis C deaths have declined by 20% in the two years since direct-acting antivirals were added to the PBS, infectious…
Read more
GPs are hungry for knowledge about managing five common conditions, an NPS Medicinewise update suggests. A list of…
Read more
PBS listing of direct acting antivirals (DAAs) for hepatitis C has failed to persuade 95% of GPs to prescribe them, a survey…
Read more
Leading Australian gastroenterologists have urged doctors not to be swayed by a “flawed” study that claims new direct-acting…
Read more